BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
IL1A
,
T cell differentiation
,
Breast Cancer
,
Intestine
,
Bleomycin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
nucleosidic inhibitors
NextBio Summary
General Info
Curated Studies
Most Correlated Studies
Broad Connectivity Map (CMAP 2.0) compound database
Drug target sets for approved compounds
Drug Matrix In Vivo Toxicogenomic Study - Rat Liver [Codelink]
Liver Pharmacology and Xenobiotic Response Repertoire
Drug Matrix In Vivo Toxicogenomic Study - Rat Kidney [Codelink]
Explore Curated Studies Results
Literature
Most Relevant Literature
Microwave-assisted synthesis of novel purine nucleosides as selective cholinesterase inhibitors.
Synthesis of 1'-C-cyano pyrimidine nucleosides and characterization as HCV polymerase inhibitors.
Ectonucleotidase inhibitors: a patent review (2011-2016).
Pyrrolo[2,1-f][1,2,4]triazines: From C-nucleosides to kinases and back again, the remarkable journey…
Recent advances on the enantioselective synthesis of C-nucleosides inhibitors of inosine monophospha…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study to Evaluate the Replacement of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors by Nevir…
Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)…
TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efa…
Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD
A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retr…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ